Silicon Laboratories (NASDAQ:SLAB) SVP Brandon Tolany sold 9,060 shares of the business’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $91.47, for a total value of $828,718.20. Following the transaction, the senior vice president now directly owns 44,246 shares of the company’s stock, valued at $4,047,181.62. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Brandon Tolany also recently made the following trade(s):
- On Monday, January 29th, Brandon Tolany sold 18,235 shares of Silicon Laboratories stock. The stock was sold at an average price of $95.00, for a total value of $1,732,325.00.
Shares of Silicon Laboratories (NASDAQ SLAB) traded down $2.40 on Tuesday, reaching $90.80. The company had a trading volume of 300,900 shares, compared to its average volume of 249,285. The company has a debt-to-equity ratio of 0.36, a current ratio of 5.84 and a quick ratio of 5.39. The firm has a market capitalization of $3,877.94, a P/E ratio of 83.30, a price-to-earnings-growth ratio of 2.40 and a beta of 1.41. Silicon Laboratories has a 52-week low of $66.35 and a 52-week high of $100.00.
Silicon Laboratories (NASDAQ:SLAB) last announced its quarterly earnings results on Wednesday, January 31st. The semiconductor company reported $0.93 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.86 by $0.07. The firm had revenue of $201.02 million during the quarter, compared to the consensus estimate of $197.93 million. Silicon Laboratories had a return on equity of 11.11% and a net margin of 6.12%. The firm’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same period in the prior year, the company posted $0.75 earnings per share. equities research analysts predict that Silicon Laboratories will post 2.52 EPS for the current fiscal year.
A number of equities analysts have recently commented on the company. Zacks Investment Research downgraded Silicon Laboratories from a “hold” rating to a “sell” rating in a research report on Wednesday, February 7th. Needham & Company LLC reissued a “buy” rating and set a $115.00 price objective (up from $110.00) on shares of Silicon Laboratories in a research report on Thursday, February 1st. Drexel Hamilton reissued a “buy” rating and set a $111.00 price objective (up from $103.00) on shares of Silicon Laboratories in a research report on Wednesday, January 31st. Roth Capital boosted their price objective on Silicon Laboratories from $105.00 to $110.00 and gave the stock a “buy” rating in a research report on Tuesday, January 30th. Finally, B. Riley reissued a “buy” rating on shares of Silicon Laboratories in a research report on Monday, January 29th. One research analyst has rated the stock with a sell rating, one has given a hold rating and eight have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $102.89.
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. BlackRock Inc. boosted its holdings in Silicon Laboratories by 2.2% in the fourth quarter. BlackRock Inc. now owns 4,765,980 shares of the semiconductor company’s stock valued at $420,837,000 after purchasing an additional 102,811 shares in the last quarter. State Street Corp boosted its holdings in Silicon Laboratories by 5.1% in the second quarter. State Street Corp now owns 1,520,505 shares of the semiconductor company’s stock valued at $103,925,000 after purchasing an additional 74,439 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in Silicon Laboratories by 9.4% in the third quarter. Bank of New York Mellon Corp now owns 920,839 shares of the semiconductor company’s stock valued at $73,574,000 after purchasing an additional 79,247 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Silicon Laboratories by 0.4% in the third quarter. Dimensional Fund Advisors LP now owns 895,422 shares of the semiconductor company’s stock valued at $71,546,000 after purchasing an additional 3,229 shares in the last quarter. Finally, Alliancebernstein L.P. boosted its holdings in Silicon Laboratories by 0.7% in the fourth quarter. Alliancebernstein L.P. now owns 516,390 shares of the semiconductor company’s stock valued at $45,597,000 after purchasing an additional 3,675 shares in the last quarter. 89.66% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY NOTICE: “Silicon Laboratories (SLAB) SVP Brandon Tolany Sells 9,060 Shares” was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/20/silicon-laboratories-slab-svp-brandon-tolany-sells-9060-shares.html.
Silicon Laboratories Company Profile
Silicon Laboratories Inc is a provider of silicon, software and solutions for the Internet of Things (IoT), Internet infrastructure, industrial, consumer and automotive markets. The Company operates through mixed-signal analog intensive products segment. It provides analog-intensive, mixed-signal solutions for use in a range of electronic products in various applications for the IoT market.
Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.